XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Financial Condition - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Assets    
Cash and cash equivalents ($3.8 million and $3.9 million restricted from use at September 30, 2018 and December 31, 2017, respectively) $ 125,396 $ 267,646
Advisory fees receivable, net of allowance for doubtful accounts of $0.0 million and $0.3 million at September 30, 2018 and December 31, 2017, respectively 86,767 64,244
Other receivables 2,973 3,964
Property and equipment, net of accumulated depreciation of $44.4 million and $62.1 million at September 30, 2018 and December 31, 2017, respectively 7,501 8,602
Goodwill 209,137 217,737
Deferred tax asset, net 41,547 42,345
Other assets 12,268 6,279
Total assets 485,589 610,817
Liabilities and Equity    
Compensation payable 41,532 26,022
Accounts payable and accrued expenses 23,300 15,443
Current income taxes payable 8,886 5,311
Secured term loan payable 327,653 339,048
Contingent obligation due selling unitholders of Cogent 17,784 13,763
Deferred tax liability 3,759 2,928
Total liabilities 422,914 402,515
Common stock, par value $0.01 per share; 100,000,000 shares authorized, 44,906,164 and 43,750,170 shares issued as of September 30, 2018 and December 31, 2017, respectively; 21,000,919 and 27,084,520 shares outstanding as of September 30, 2018 and December 31, 2017, respectively 449 438
Restricted stock units 64,706 80,512
Additional paid-in capital 842,437 800,806
Exchangeable shares of subsidiary; 257,156 shares issued as of September 30, 2018 and December 31, 2017; 32,804 shares outstanding as of September 30, 2018 and December 31, 2017 1,958 1,958
Retained earnings 53,620 37,595
Accumulated other comprehensive income (loss) (31,924) (22,222)
Treasury stock, at cost, par value $0.01 per share; 23,905,245 and 16,665,650 shares as of September 30, 2018 and December 31, 2017, respectively (868,571) (690,785)
Stockholders’ equity 62,675 208,302
Total liabilities and equity $ 485,589 $ 610,817